12
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1172 |
Diclazuril
地克珠利,R-64433 |
Antibiotic; Parasite | Microbiology/Virology |
Diclazuril (R-64433) 是一种具有口服活性的抗球虫剂,是苯乙腈衍生物。它可用于某些传染病和寄生虫病的相关研究。 | |||
T25549 |
JCP174
JCP 174,JCP-174 |
Serine Protease | Proteases/Proteasome |
JCP174是一种去棕榈酰化酶抑制剂,可通过靶向 TgPPT1增强弓形虫的宿主细胞侵袭。 | |||
T78605 |
CpCDPK1/TgCDPK1-IN-1
|
Bcr-Abl; Src | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
CpCDPK1/TgCDPK1-IN-1 是一种高效的 CpCDPK1 和 TgCDPK1 双重抑制剂,抑制 Abl 和 Src,具有抗寄生虫活性,适用于研究弓形虫感染和隐孢子虫病。 | |||
T72081 |
CpCDPK1/TgCDPK1-IN-2
|
Parasite | Microbiology/Virology |
CpCDPK1/TgCDPK1-IN-2 是 CpCDPK1 和 TgCDPK1 双重抑制剂,对 CpCDPK1 和 TgCDPK1 有抑制这样,IC50 值分别为 12 和 5 nM。CpCDPK1/TgCDPK1-IN-2 可用于研究弓形虫 (T. gondii)、细小隐孢子虫 (C. parvum) 和隐孢子虫 (C. hominus) 等顶复门原生动物感染相关疾病。 | |||
T36692 |
Fanotaprim
|
DHFR | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Fanotaprim 是二氢叶酸还原酶的有效抑制剂,抑制 tgDHFR (Toxoplasma gondiiDHFR) 和 hDHFR (human DHFR)的 IC50分别为 1.57 和 308 nM。Fanotaprim 在研究弓形虫病方面具有价值。 | |||
T72033 |
pCDPK1/TgCDPK1-IN-3
|
Parasite | Microbiology/Virology |
CpCDPK1/TgCDPK1-IN-3 是一种 CpCDPK1 和 TgCDPK1双重抑制剂,对 CpCDPK1 的IC50 为 0.003µM ,对TgCDPK1 的IC50 为 0.0036 µM。CpCDPK1/TgCDPK1-IN-3 可用于研究像弓形虫 、细小隐孢子虫 和隐孢子虫等顶复门原生动物相关疾病感染。 | |||
T69311 |
GW300657X
|
||
GW300657X is a small molecule inhibitor that blocks toxoplasma gondii rhoptry kinase 18 and maintains moderate CDK2-cyclin A inhibitory activity. | |||
T29003 |
TRC-19
|
||
TRC-19 is a potent and selective inhibitor of Toxoplasma gondii dihydrofolate reductase. TRC-19 shows an IC50 of 9 nM and 89-fold selectivity in favor of Toxoplasma gondii dihydrofolate reductase. | |||
T61671 |
MMV687807
|
||
MMV687807 is a potent anthelmintic compound exhibiting strong efficacy against Toxoplasma gondii (T. gondii). It demonstrates an IC50 value of 0.15 μM and a CC50 value of 1.69 μM [1]. | |||
T76121 |
Phosphoglucomutase
|
Endogenous Metabolite | Metabolism |
Phosphoglucomutase可促进弓形虫的囊肿发育。缺乏 Phosphoglucomutase 会引发代谢疾病。 | |||
T62333 | Anti-Trypanosoma cruzi agent-1 | ||
Anti-Trypanosoma cruzi agent-1 (Compd E5) 具有有效的抗弓形虫效果。 | |||
T38269 | Purfalcamine | ||
Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage[1][2]. Purfalcamine has low activity against Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3)[1]. Purfalcamine (225, 450 nM) has no effect on the parasitemia in the first 32 hours. After about 40 hours, paras... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN7103 |
13,21-Dihydroeurycomanone
Pasakbumin C |
Anti-infection; Parasite | Microbiology/Virology |
13,21-Dihydroeurycomanone (Pasakbumin C) 是从 Eurycoma longifolia 根部分离得到的一种天然产物,有抗寄生虫活性。 | |||
T0819 |
Spiramycin
Espiramicin,螺旋霉素,Sequamycin,Rovamycin,Provamycin,Formacidine |
Antibacterial; Antibiotic; Parasite | Microbiology/Virology |
Spiramycin (Rovamycin) 是一种由安博链霉菌产生的大环内酯类抗生素,具有抗细菌和弓形虫活性,并具有抗寄生虫作用。它由 16 个内酯环组成,其上附着 mycaminose,forosamine 和 mycarose 三种糖。 | |||
T35750 |
Trypacidin
|
||
Trypacidin is a fungal metabolite originally isolated fromA. fumigatus.1It is active againstB. subtilisandM. bovis(MICs = 12.5 and 1.25 μg/ml, respectively), as well asT. cruziandT. gondii(MICs = 5-10 and 10-20 μg/ml, respectively).1,2It reduces viability and induces lysis of A549 human lung cancer cells (IC50s = 7.4 μM for both).3Trypacidin increases survival in a mouse model ofT. gondiiinfection when administered in six doses of 12.5 mg/kg each.1 1.Balan, J., Ebringer, L., Nemec, P., et al.Ant... |